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OBJECTIVE — Early puberty is associated with increased risk of subsequent cardiovascular
disease. Low sex hormone–binding globulin (SHBG) levels are a feature of early puberty and of
conditions associated with increased cardiovascular risk. The aim of the present study was to
evaluate SHBG as a predictor of glucose metabolism and metabolic risk during puberty.
RESEARCH DESIGN AND METHODS — This was a cross-sectional study on 132
healthy Caucasian children and adolescents evaluated by an oral glucose tolerance test, a dual-
energy X-ray absorptiometry scan, direct oxygen uptake measurement during cycle ergometry,
and fasting blood samples.
RESULTS — SHBG levels declined with advancement of puberty in both boys (P  0.001)
and girls (P  0.019). SHBG was signiﬁcantly positively associated with insulin sensitivity in
boys (P  0.001) and girls (P  0.001). In addition, SHBG was a strong predictor of insulin
sensitivity (P  0.001) and the only predictor of the disposition index (P  0.031) after
adjustment for puberty, fat mass, and aerobic ﬁtness. SHBG was signiﬁcantly negatively associ-
ated with metabolic risk (P  0.032) and with hypersensitive C-reactive protein levels (P 
0.030) after adjustment for relevant confounders.
CONCLUSIONS — SHBG was a strong predictor of insulin sensitivity and metabolic risk
during puberty. Thus, we hypothesize that SHBG integrates the marked changes in glucose
metabolism and body composition that occur during the pubertal transition.
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E
arly puberty has been associated
with increased cardiovascular risk in
adulthood (1–3), the underlying
mechanism of which is unknown. How-
ever, a shared feature of both early pu-
bertyandcardiovascularriskislowserum
levels of sex hormone–binding globulin
(SHBG).
In adults, SHBG levels are negatively
associated with a cluster of conditions, all
of which have a strong association with
obesity and insulin resistance. Thus, low
levels of SHBG have consistently been as-
sociatedwithawidearrayofcardiovascu-
lar risk factors including visceral and
subcutaneous adiposity, hypertension,
dyslipidemia, and insulin resistance
(4,5). Consequently, SHBG levels are low
in overt type 2 diabetes and have more
recently been associated with the meta-
bolicsyndrome(6–8).Inaddition,SHBG
levels have been found to be a determi-
nantofcardiovascularriskindependently
of obesity and insulin resistance (9) and
can be used to predict future type 2 dia-
betes and metabolic syndrome in adults
(7,10).
DespitetheincreasingfocusonSHBG
as a marker of cardiovascular risk in
adults, few studies have examined the re-
lationofSHBGtoglucosemetabolismand
metabolic risk during puberty. SHBG lev-
els have been negatively associated with
fasting insulin levels (11), body composi-
tion, and sex steroid levels (12) during
puberty. We have recently shown that
early pubertal timing in girls is associated
withlowerSHBGlevelsthanpredictedby
pubertal stage and BMI (12), suggesting
that differences in glucose metabolism
could be at least partly responsible. How-
ever, no study to date has evaluated the
predictive value of SHBG on glucose me-
tabolism during puberty.
The aim of the present study was to
investigate SHBG as a predictor of insulin
sensitivity, insulin secretion, and meta-
bolicriskaftercorrectionforotherknown
inﬂuential confounders such as puberty,
adiposity, and aerobic ﬁtness.
RESEARCH DESIGN AND
METHODS— All participants were
recruited as a part of the Copenhagen Pu-
bertyStudyfromthreeprimaryschoolsin
the Copenhagen community. A total of
132 healthy Caucasian children and ado-
lescents (70 girls) aged 8.5–16.1 years
volunteered. No prior or present medical
historyofconfoundingconditionswasre-
ported. Four of the adolescent girls were
excluded from analysis of SHBG because
of intake of contraceptive pills. No other
intakes of medications were reported. All
participants ﬁlled out a lifestyle question-
naire. None of the participants were
smokers or reported consuming alcohol.
The median time spent on physical activ-
ity was 5–6 h/week. Median hours spent
perdayinfrontofthetelevisionandcom-
puter were 1–2 and 1 h, respectively.
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Pubertal development was described ac-
cording to the Tanner classiﬁcation. The
date of last menstrual bleeding was re-
corded in postmenarchal girls (n  21).
Body composition
Whole-body dual-energy X-ray absorpti-
ometry scanning was performed on all
subjects using a Hologic CDR 1000/W
densitometer (Hologic, Bedford, MA)
with software version 6.2. Waist circum-
ference was measured three times at the
midaxillary line at the level midway be-
tweentheanteriorsuperioriliacspineand
the 12th rib.
Aerobic ﬁtness
Maximal oxygen uptake (VO2max) was as-
sessedduringacycleergometrytestusing
an electronically braked cycle ergometer
(Ergomedic 839; Monark, Varberg, Swe-
den).VO2maxwasmeasureddirectlyusing
an online pulmonary gas analyzer system
(Quark CPET; Cosmed, Rome, Italy). Ini-
tial and incremental workloads were 20
W for children weighing 30 kg and 25
W for children weighing 30 kg. For ad-
olescents 15 years of age, initial work-
load was 70 W for girls and 100 W for
boys, and incremental workload was 35
W. Workload was increased every third
minute until exhaustion for children and
adolescents 15 years of age, and every
second minute until exhaustion for ado-
lescents 15 years of age. Heart rate was
recorded continuously throughout the
testusingaheartratemonitor(PolarElec-
tro, Oulu, Finland). Criteria for a maxi-
mal effort were heart rate of 185 beats/
min and a subjective judgment by the
observer that the individual could no
longer continue, even after encourage-
ment. For a valid directly measured test,
the oxygen consumption curve should
show signs of leveling off. The cycle er-
gometer was electronically calibrated on
everytestday.Maximaloxygenconsump-
tion per kilogram body weight is an ex-
pression of aerobic ﬁtness.
Two subjects could not participate in
cycle ergometry because of a foot injury;
122 (92.4%) subjects fulﬁlled the criteria
for a valid cycle ergometry test, of which
only 113 (85.6%) had a valid directly
measured Vcm;1o2max owing to technical
problems with the online pulmonary gas
analyzer system. To include all partici-
pants with a valid cycle ergometry test,
the predicted VO2max was estimated by
linear regression analysis from the maxi-
mal power output from all participants
with valid direct VO2max.
VO2max boys  (maximal power output
 12.2)  368.9
VO2max girls  (maximal power output
 12.4)  303.9
The estimated values were highly signiﬁ-
cantly correlated to the direct measure-
ments in both boys (r  0.938) and girls
(r  0.895).
Blood sampling
An intravenous cannula was inserted into
an antecubital vein, from which fasting
venous blood samples were drawn into
standardvacuumtubes.Bloodwascentri-
fuged (3,000g at 10 min), and plasma
samples were isolated and stored at
20°C until analysis.
Oral glucose tolerance test
Standard 2-h oral glucose tolerance tests
(OGTTs) with an oral glucose load of
1.75 g glucose/kg body weight (maxi-
mum75gglucose)wereperformedforall
subjects. Blood samples were drawn with
30-min intervals. Blood was centrifuged
within 30 min, and plasma was immedi-
atelystoredat20°Cuntildetermination
of insulin and glucose levels. The areas
under the curve for plasma glucose and
insulin were calculated by the trapezoidal
rule. The whole-body insulin sensitivity
index (WBISI) was calculated by the for-
mula developed by Matsuda and De-
Fronzo (13) and subsequently converted
to picomoles per liter insulin per milli-
moles per liter glucose. First-phase insu-
lin release was calculated by the formula
developed by Stumvoll et al. (14). -Cell
compensatory capacity was evaluated by
the disposition index, as the product of
WBISI and ﬁrst-phase insulin release (1st
PH), which has recently been validated
from OGTTs in adults (15). Application
of the same statistical model (see STATIS-
TICS) to the values from the present chil-
dren conﬁrmed the rectangular
hyperbolic relationship with the follow-
ing formula: 1347.8/WBISI  516.9 
1st PH (R
2  0.512, P  0.001).
Analyses
SHBG was determined by a time-resolved
immunoﬂuorescence assay (Delﬁa; Wal-
lac Oy, Turku, Finland) with a detection
limit of 0.23 nmol/l. Intra- and interassay
coefﬁcients of variation (CVs) were 5.8
and6.4%,respectively.Insulinwasdeter-
mined by an electrochemiluminescence
immunoassay (Elecsys insulin reagents
kit; Roche Diagnostics, Mannheim, Ger-
many) on an automated Roche Modular
Analytics Module E170 (Roche Diagnos-
tics). The detection limit was 2 pmol/l.
The intra- and interassay CVs were 4.2
and 8.2%, respectively. Glucose, lipids
(HDL cholesterol and triglycerides),
and hypersensitive C-reactive protein
(hsCRP) were all determined on a Roche
ModularAnalyticsSWAModuleP(Roche
Diagnostics). Glucose was determined by
enzymatic absorption photometry, and
theintra-andinterassayCVswere1.1and
1.7%, respectively. HDL cholesterol and
triglycerides were determined by enzy-
matic colorimetric analyses (CFAS HDL
plus, triglyceride GPO-PAP; Roche Diag-
nostics). For HDL, the intra- and interas-
sayCVswere0.9and1.85%,respectively.
Fortriglycerides,theintra-andinterassay
CVs were 1.5 and 1.8%, respectively.
hsCRP levels were determined by immu-
noturbidimetric analyses (Cobas; Roche
Diagnostics),andtheintra-andinterassay
CVs were 1.0 and 2.4%, respectively.
Blood pressure
Blood pressure was measured with a con-
ventional sphygmomanometer (Heine
Gamma G5; Heine Optotechnik, Herr-
sching am Ammersee, Germany) in the
left arm after a 10-min rest in the supine
position.
Metabolic syndrome score
Metabolicsyndromeisdeﬁnedasacluster
of dyslipidemia, hypertension, glucose
intolerance, and obesity in adults. Until
recently, no deﬁnition of the metabolic
syndromeexistedforchildrenandadoles-
cents, but the International Diabetes Fed-
eration (IDF) came out with a consensus
in 2007 (16). No participant met the di-
agnostic criteria of metabolic syndrome
based on the IDF criteria. To evaluate the
metabolic parameters as a continuous
variable, we generated a combined Z
score based on the ﬁve variables included
in the IDF consensus. Age- and sex-
speciﬁc Z scores for waist circumference
were obtained by using combined cross-
sectional and longitudinal data from the
Copenhagen Puberty Study, with 2,103
observations on 1,093 girls and 765 boys
(K.S.,L.A.,A.J.,unpublisheddata).TheZ
score for HDL cholesterol was inversed
because of the negative association with
metabolic syndrome. All ﬁve Z scores
were added and subsequently divided by
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tive and negative scores indicating val-
ues higher and lower, respectively, than
the mean risk proﬁle for this speciﬁc
population.
Statistics
No differences in outcome variables were
foundbetweenpostmenarchalgirlstested
during the luteal phase versus the follicu-
lar phase, and data were pooled before
analyses. Descriptive statistics are shown
asmedians(10thpercentile;90thpercen-
tile).Mann-WhitneyUtestswereusedfor
nonparametric comparison between
groups. SHBG, fat mass, insulin sensitiv-
ity, insulin secretion, disposition index,
and hsCRP were log-transformed to ob-
tain approximate normal Gaussian distri-
bution of the residuals and to obtain a
residual variance that did not depend on
thelevel.Generallinearmodelswereused
to assess the main determinants of insulin
sensitivity, insulin secretion, disposition
index, metabolic risk score, and hsCRP,
respectively.Nointeractionsbetweenpu-
berty and sex were observed in any of
these models. Analyses with insulin sen-
sitivity, insulin secretion, and disposition
index as dependent variables, respec-
tively, included the following covariates:
sex, age, puberty, fat mass, SHBG, and
aerobic ﬁtness.
To conﬁrm the inverse relationship
between insulin secretion and insulin
sensitivity, a regression analysis was done
usingthefollowingmodel:1stPHcon-
stant  WBISI
 3 log (1st PH)  con-
stant log(WBISI). The inverse
relationship was conﬁrmed with 
0.583 and a 95% CI of  from 0.691
to 0.474. A linear regression analysis
was done with direct measured VO2max as
the response and maximal power output
as the explanatory variable to predict the
VO2max in all subjects with a valid cycle
ergometry test, including those with in-
valid direct measurements of Vo2max.N o
other variables contributed signiﬁcantly
in this regression.
Ethics
The study was performed in accordance
with the ethnical principles of the Decla-
ration of Helsinki II. The study protocol
was approved by the local ethics commit-
tee (reference nos. KF 01 282214 and KF
11 2006-2033). All children and parents
gave their informed written consent.
RESULTS— Descriptive characteris-
ticsaccordingtosexareshowninTable1.
SHBG levels decreased with increas-
ing stage of puberty in boys (P  0.001)
and girls (P  0.019), respectively. How-
ever, SHBG levels in girls tended to pla-
teau during midpuberty, after which a
slight nonsigniﬁcant increase was noted.
Girls had statistically signiﬁcantly higher
SHBG levels (P  0.023) than boys after
adjustmentforage,puberty,fatmass,and
insulin sensitivity.
Insulin sensitivity during puberty in
relation to SHBG levels above and below
the median is illustrated in Fig. 1A.I n
univariate analyses, insulin sensitivity
was signiﬁcantly positively associated
with SHBG and aerobic ﬁtness and nega-
tively associated with fat mass in boys
(P  0.001, P  0.042, and P  0.001,
respectively) and in girls (all P  0.001).
SHBG remained a signiﬁcant predictor of
insulin sensitivity after adjustment for fat
mass and aerobic ﬁtness (Table 2).
Insulin secretion during puberty in
relation to SHBG levels above and below
themedianisillustratedinFig.1B.Inuni-
variateanalyses,insulinsecretionwassig-
niﬁcantly positively associated with
SHBG and fat mass and negatively associ-
ated with aerobic ﬁtness in boys (P 
0.009,P0.001,andP0.013,respec-
tively) and in girls (all P  0.001). How-
ever, SHBG was no longer a signiﬁcant
predictor of insulin secretion after adjust-
ment for insulin sensitivity.
Disposition index during puberty in
relation to SHBG levels above and below
the median is shown in Fig. 1C. SHBG
was signiﬁcantly negatively associated
with disposition index (P  0.005). Nei-
ther fat mass nor aerobic ﬁtness were sig-
niﬁcantly associated with disposition
index in univariate analyses. SHBG and
puberty contributed the most to the vari-
ance in disposition index (P  0.004,
R
2  0.08). Predictors of disposition in-
dex are shown in Table 2.
Metabolic risk during puberty was
evaluatedbythecombinedZscoreonrisk
factors derived from the recent IDF con-
sensus on childhood metabolic syn-
drome. Metabolic risk during puberty in
relation to SHBG levels above and below
themedianisshowninFig.1D.Metabolic
risk was negatively associated with SHBG
and aerobic ﬁtness and positively associ-
atedwithfatmassinboys(P0.001,P
0.002, and P  0.001, respectively) and
in girls (P  0.003, P  0.001, and P 
0.001, respectively). Predictors of meta-
bolic risk are shown in Table 2.
hsCRPlevelswerenotassociatedwith
puberty per se. hsCRP was positively as-
sociated with metabolic risk and fat mass
and negatively associated with SHBG and
Table 1—Descriptive characteristics
Boys Girls P*
n 62 70
Pubertal stage 1–5 (%) 34; 24; 11; 11; 19 14; 11; 19; 43; 13
Age (years) 12.4 (9.2; 14.9) 12.3 (9.1; 15.2) NS
Fat mass (kg) 7.5 (5.1; 15.8) 9.6 (5.2; 15.0) 0.042
Lean mass (kg) 34.1 (23.7; 52.8) 32.5 (22.4; 44.2) NS
Fasting insulin (pmol/l) 43 (21; 72) 49 (32; 91) 0.010
Fasting glucose (mmol/l) 4.8 (4.1; 5.5) 4.8 (4.2; 5.3) NS
Mean AUCinsulin (pmol/l) 242 (118; 379) 248 (155; 458) NS
Mean AUCglucose (mmol/l) 5.8 (4.5; 7.3) 5.5 (4.6; 6.7) NS
WBISI‡ 2.1 (1.3; 4.3) 1.9 (1.0; 3.0) NS
Insulin release (pmol)§ 1,002 (635; 1,647) 1,305 (876; 2,088) 0.003
Disposition index 2,260 (1,377; 3,924) 2,492 (1,524; 3,555) NS
Vo2max (ml   kg
1   min
1) 46.8 (35.6; 55.0) 40.0 (33.4; 48.0) 0.001
Triglycerides (mmol/l) 0.61 (0.43; 1.11) 0.79 (0.53; 1.36) 0.001
HDL cholesterol (mmol/l) 1.47 (1.15; 1.88) 1.52 (1.04; 1.84) NS
Mean ABP (mmHg) 78.3 (70.0; 93.3) 76.7 (71.7; 90.0) NS
Waist circumference Z score 0.22 (0.99; 1.34) 0.07 (1.02; 1.32) NS
Metabolic Z score¶ 0.13 (0.56; 0.78) 0.04 (0.53; 0.77) NS
hsCRP (mg/l) 0.28 (0.16; 1.40) 0.28 (0.16; 2.68) NS
SHBG (nmol/l) 63.0 (23.0; 122.0) 81.5 (34.5; 130.5) NS
Data are medians (10th percentile; 90th percentile). *Comparisons between boys and girls by a Mann-
Whitney U test. ‡Insulin sensitivity (ref. 13). §Insulin release as ﬁrst-phase (ref. 14). VO2max indicates
predictedaerobicﬁtness.¶ZscorerepresentstheSDscore.ABP,arterialbloodpressure;AUC,areaunderthe
curve. NS, nonsigniﬁcant (P  0.05).
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both boys (P  0.002, P  0.001, P 
0.003, and P  0.001, respectively) and
girls (P  0.006, P  0.035, P  0.018,
and P  0.006, respectively). After ad-
justment for fat mass and aerobic ﬁtness,
both SHBG (P  0.030) and metabolic
risk(P0.019)remainedsigniﬁcantpre-
dictors of hsCRP during puberty.
CONCLUSIONS — In the present
studyofhealthychildrenandadolescents,
we found strong associations between
SHBG levels and markers of glucose me-
tabolism and metabolic risk. SHBG was a
signiﬁcant positive predictor of insulin
sensitivity and disposition index during
puberty independent of fat mass and aer-
obic ﬁtness. In addition, SHBG negatively
predicted childhood metabolic risk and
low-grade inﬂammation.
Early puberty has been associated
with an increased risk of insulin resis-
tance, dyslipidemia, and adiposity in
adulthood (1–3). The underlying mecha-
nism responsible for this association is
unknown, but a shared feature of both
conditions is low SHBG levels.
In accordance with previous studies
(11,12), SHBG levels declined during pu-
berty in boys and girls, although levels in
girls tended to plateau from around mid-
puberty. During puberty, SHBG levels
have been associated with body composi-
tion, sex steroids (12), and fasting insulin
levels(11).Interestingly,girlswithpreco-
cious puberty have lower SHBG levels
than predicted by pubertal stage and BMI
(12), indicating that some of the residual
variation in SHBG in such patients might
be related to differences in insulin sensi-
tivity and secretion.
Puberty is characterized by a marked
physiological decline in insulin sensitiv-
ity, leading to a compensatory increase in
insulin secretion, both of which recover
by late puberty (17). In the present study,
a similar curvilinear pattern with declin-
ing insulin sensitivity and increasing in-
sulin responses until midpuberty was
conﬁrmed. Because of the inverse rela-
tionship between insulin sensitivity and
insulin secretion, it has been speculated
that risk assessment for future develop-
ment of type 2 diabetes is most accurately
measured during periods of -cell chal-
lenge (18). Pregnancy may constitute
such an example in that -cells are chal-
lenged by low insulin sensitivity. Low
SHBG levels during the ﬁrst trimester of
pregnancy predict gestational diabetes
mellitus (19), which has been found to be
strongly associated with subsequent de-
velopment of overt type 2 diabetes (18).
In analogy, puberty might constitute a
comparablesensitiveperiodduringchild-
hood and adolescence in which low
SHBGmightpredictincreasedriskoftype
2 diabetes and related metabolic changes.
Previous studies in adults have con-
sistently shown strong correlations be-
tween SHBG and different indexes of
insulin sensitivity (8,20). A similar posi-
tive correlation has been found in chil-
dren and adolescents during puberty,
although this has previously only been
studied in relation to fasting insulin levels
(11). In the present study, we found in-
sulin sensitivity assessed by OGTT to be
strongly associated with SHBG levels in
both boys and girls during puberty. In
addition, SHBG was a strong predictor of
insulin sensitivity independently of fat
mass and aerobic ﬁtness. In accordance
with previous studies (21), insulin sensi-
tivity was strongly associated with both
Figure 1— Insulin sensitivity (A), insulin secretion (B), disposition index (C), and metabolic Z
score (D) during puberty based on OGTTs in healthy children and adolescents. For each pubertal
stage,theeffectoflowversushighSHBGlevelsisillustratedbygroupingallchildrenaccordingto
themedianSHBGlevelforpubertalstageandsex.f,belowmedianSHBGgroup; ,abovemedian
SHBG group. The whiskers represent the 90th percentiles. Insulin sensitivity (WBISI) (ref. 13)
andinsulinsecretion(ﬁrst-phaserelease)(ref.14)werecalculatedusingglucoseinmillimolesper
liter and insulin in picomoles per liter concentrations. To convert WBISI to glucose in milligrams
per deciliter and insulin in microunits per milliliter, multiply by a factor 3. To convert insulin
secretion from picomoles per liter to microunits per milliliter, divide by a factor 6. Disposition
index was calculated as the product of insulin sensitivity and insulin secretion. The metabolic Z
score is generated by combining Z scores from fasting glucose, triglyceride levels, inverse HDL
cholesterol levels, waist circumference, and mean blood pressure levels divided by 5. An increase
in the combined Z score indicates an increase in metabolic risk.
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cause of the strong interrelation between
aerobic ﬁtness and fat mass, these covari-
ates explain much of the same variability
in insulin sensitivity and therefore are
nonsigniﬁcant when both are included in
the same variance analysis.
Insulin secretion was strongly posi-
tivelyassociatedwithSHBGbutnotwhen
adjusted for insulin sensitivity. To evalu-
atethepredictivevalueofSHBGon-cell
function,wecalculatedthedispositionin-
dex by a method that has recently been
validated during OGTTs (15). The dispo-
sition index was lowest during midpu-
berty, which is in accordance with
previous studies (17). As reported in
adults (22), we found that SHBG was sig-
niﬁcantly associated with the disposition
index. In addition, SHBG was the only
signiﬁcant predictor of the disposition in-
dex during puberty. However, it should
be noted that SHBG and puberty only ac-
counted for 8% of the variance in dis-
position index.
Obesityandinsulinresistancearema-
jor risk factors for development of the
metabolic syndrome in children and ado-
lescents (16,23). In light of the strong as-
sociations between SHBG levels,
adiposity, and insulin resistance (8,20), it
is not surprising that SHBG levels have
beenshowntobestronglyassociatedwith
the metabolic syndrome and overt type 2
diabetes in adults (6–8). In the present
study, we found SHBG to be a signiﬁcant
predictor of the combined Z score on all
variables derived from the IDF consensus
on childhood metabolic syndrome, even
after adjustment for fat mass and aerobic
ﬁtness.Inaccordancewithpreviousstud-
ies (24), aerobic ﬁtness did not indepen-
dently predict metabolic risk in these
children, indicating that aerobic ﬁtness
inﬂuences metabolic risk indirectly
through effects on fat mass. However, the
metabolic syndrome score is partially
based on waist circumference, an abdom-
inal fat mass estimate, and therefore is ﬁt-
tedtobestronglyassociatedwithfatmass
per se. Thus, coexistence of adverse met-
abolic characteristics was independently
associated with low SHBG levels, indicat-
ing that SHBG might be valuable in the
assessment of cardiovascular risk during
puberty. High metabolic risk was inde-
pendently associated with high hsCRP
levels in the present study. Elevated
hsCRP levels have been associated with
the metabolic syndrome in obese chil-
dren and adolescents in previous stud-
ies(25),andthepresentﬁndingextends
this result to include nonobese children
without overt metabolic syndrome. In
addition, high hsCRP levels were asso-
ciated with low SHBG independent of
fat mass and aerobic ﬁtness. Thus,
SHBG might serve as an independent
marker of low-grade systemic inﬂam-
mation during puberty, which further
strengthens its candidacy as a predictor
of cardiovascular risk during childhood
and adolescence.
Insummary,strongassociationswere
foundbetweenSHBGandmarkersofglu-
cose metabolism in healthy nonobese
children during puberty. Importantly,
SHBG was a strong predictor of insulin
sensitivity and a predictor of disposition
index independently of total fat mass and
aerobic ﬁtness. In addition, the clustering
of adverse metabolic characteristics and
elevated hsCRP levels was independently
associated with low SHBG levels. We hy-
pothesize that SHBG integrates the
marked changes in glucose metabolism
and body composition that occur during
the pubertal transition.
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